|
AutoLumo S900 – Fully Automated Chemiluminescent Immunoassay Analyzer for Clinical Laboratories
The AutoLumo S900 reflects a broader push by Chinese diagnostics manufacturers to deliver high-throughput automation in a footprint suited for smaller clinical labs, bypassing the need for sprawling centralised facilities.
Autobio Diagnostics’ AutoLumo S900 is a fully automated chemiluminescent immunoassay analyzer engineered for small- and medium-sized laboratories that face space constraints but still require high throughput. It handles random-access testing and automated reagent handling through an intuitive touchscreen interface, reducing hands-on operation significantly.
The system supports over 150 assays covering tumor markers, hormone panels, infectious diseases, autoimmune disorders, cardiac markers, and TB-IGRA. Its five-stage magnetic separation cleaning and non-contact vortex mixing technology aim to deliver precise, reproducible results without frequent manual calibration.
For hospital labs, blood banks, and public health institutions, the S900 removes the operational friction of managing multiple benchtop analyzers by consolidating diverse test menus into a single automated platform. Real-time system monitoring further reduces downtime and manual oversight.
The shift toward compact, high-performance CLIA analyzers reflects changing procurement logic in China’s diagnostic supply chain. Rather than importing large mainframes from Western vendors, institutions now source automated systems from domestic manufacturers like Autobio — a beneficiary of standardisation in China’s reagent and consumables ecosystem.
This model lowers capital expenditure while maintaining compatibility with an expanding domestic reagent and test-kit industry. The S900’s design indicates an industrial approach that values flexibility and decentralised testing capacity over raw scale alone.
What makes the AutoLumo S900 worth watching is not just its technical specs — it is how Chinese manufacturers are redefining the cost-performance ratio for automated diagnostics, enabling a broader tier of clinical labs to operate with fewer constraints.
Why it matters:
For buyers, the S900 offers a path to full CLIA automation without requiring the floor space or budget of legacy Western alternatives. For suppliers and operators, it signals that China’s in vitro diagnostics sector now competes on workflow integration and assay breadth, not just unit price.
View Product →
|
ScientificChina — tracking China’s science, technology, and industrial systems through the lens of real-world products.
Follow ScientificChina for deeper insight into the infrastructure behind global innovation.
Visit ScientificChina.
|
|
No products in the cart.